تعد مدينة الملك فهد الطبية ‏ في الرياض من أكبر المدن الطبية المستقلة في الشرق الأوسط وبسعة إجمالية من سريرا وتضم: المستشفى الرئيس، مستشفى النساء التخصصي، مستشفى الأطفال، مستشفى التأهيل. يوجد بالمدينة أربعة مراكز: مركز الملك سلمان لطب وجراحة القلب، مركز العلوم العصبية، مركز الأورام، والمركز التخصصي للسكري والغدد الصم.

During the past decade, King Fahad Medical City conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 5 clinical trials were completed, i.e. on average, 20.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Fahad Medical City" #1 sponsor was "King Fahad Medical City" with 12 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "King Saud University" with 2 trials sponsored, "National Cancer Centre, Singapore" with 2 trials sponsored and "National Center for Complementary and Alternative Medicine, Saudi Arabia" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Fahad Medical City" #1 collaborator was "King Fahad Medical City" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Almarai" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Canadian Critical Care Trials Group" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "King Fahad Medical City" are "Breast Cancer" (3 trials), "Colitis, Ulcerative" (2 trials), "Crohn Disease" (2 trials), "Irritable Bowel Syndrome" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "King Fahad Medical City" in a lesser frequency.

Most popular intervention types in "King Fahad Medical City" are "Drug" (13 trials), "Device" (6 trials), "Other" (3 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CT Scan" (2 trials), "wet cupping" (2 trials), "Abemaciclib" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Fahad Medical City" are 32 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "King Fahad Medical City". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in King Fahad Medical City, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in King Fahad Medical City, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".

King Fahad Medical City has several departments that took part in Clinical trials: "King Fahad Medical City; Gastroentrology" - 6 trials, "King Fahed Medical City - Prince Salman Cardiac Center" - 2 trials